Viela Bio is a clinical-stage biotechnology company pioneering and advancing treatments for severe inflammation and autoimmune diseases. The Company's portfolio selectively targets shared critical pathways that are the root cause of disease.
Market
Severe inflammation and autoimmune diseases
Location
Gaithersburg,
MD,
USA
Coinvestors
6 Dimensions Capital, Boyu Capital, Hillhouse Capital Group, Sirona Capital, Temasek